
Near-infrared (NIR) analysis works by shining near-infrared light onto a sample and measuring how the sample absorbs or reflects that light. Because chemical bonds such as O-H, N-H, and C-H respond to NIR light in characteristic ways, the resulting spectrum can reveal information about composition, moisture, uniformity, and physical changes without destroying the material. BOC Sciences provides tailored NIR analysis services for APIs, excipients, intermediates, powders, granules, tablets, capsules, suspensions, and formulation prototypes. By combining advanced spectroscopy testing, chemometric modeling, orthogonal reference methods, and fit-for-purpose sampling strategies, we help drug development scientists convert complex spectral information into reliable decisions for formulation development, process optimization, raw material assessment, and product quality research.
We design NIR methods around your molecule, matrix, sample form, and decision objective, using our broader analytical platform to determine whether NIR can provide the right sensitivity, selectivity, and robustness for the intended application.
Our scientists build quantitative models for API assay, moisture, solvent-related variation, blend composition, coating level, and key formulation attributes using modern chemometric workflows and analytical method optimization.
We develop NIR classification methods for rapid material confirmation, grade differentiation, supplier-to-supplier comparison, counterfeit screening research, and similarity assessment, supported where useful by FTIR analysis and Raman testing.
BOC Sciences supports NIR applications for blending, drying, granulation, coating, compression, and formulation screening, integrating spectral data with formulation design and screening studies when product performance is affected by matrix structure.
BOC Sciences combines NIR spectroscopy, chemometrics, and orthogonal analytical science to help you evaluate materials faster, reduce destructive testing, and understand formulation variability with greater confidence.

Diffuse reflectance NIR is well suited for powders, granules, tablets, lyophilized solids, and opaque formulations. Our scientists optimize cup geometry, path length, rotation, packing density, and replicate strategy to reduce spectral scatter and improve sampling representativeness.

For liquids, suspensions, capsules, thin films, and semi-transparent samples, we use transmission or transflectance setups to capture bulk composition information. Path length, optical window material, sample thickness, and temperature are adjusted to prevent saturation or weak signal response.

We translate complex overtone and combination bands into usable answers using PCA, PLS, PLS-DA, SIMCA, interval selection, residual analysis, and robust preprocessing. Model interpretation is linked to chemical knowledge rather than treated as a black box.

When NIR bands overlap or matrix effects obscure interpretation, we compare results with hyphenated spectroscopic techniques, FTIR, Raman, NMR, or chromatographic data to verify molecular assignments and strengthen the final interpretation.

We help clients evaluate whether at-line or in-line NIR can provide faster feedback during blending, drying, granulation, coating, or reaction monitoring. Probe placement, optical fouling, sample motion, and model update strategy are considered from the beginning.

NIR models depend on trustworthy reference data. We align spectral acquisition with chromatography testing, moisture analysis, particle measurements, and solid-state characterization to build predictive models that reflect real sample behavior.
BOC Sciences provides NIR analysis for a broad range of pharmaceutical, biotechnology, and chemical development samples. Whether the goal is rapid identity confirmation, quantitative prediction, blend monitoring, or formulation troubleshooting, our team adapts the measurement design to the physical form and spectral complexity of each material.
Submit your target analyte, formulation matrix, available reference data, and decision goal. Our spectroscopy team will design a practical NIR strategy tailored to your sample form, analytical question, and development stage.

We review the sample matrix, target attribute, concentration range, available reference data, physical form, and expected sources of spectral variation. This step determines whether NIR is best used for identification, quantification, trending, or troubleshooting.

We optimize scan range, resolution, replicate number, sample holder, path length, probe geometry, and environmental controls. For complex materials, we compare NIR performance with HPLC testing, UHPLC testing, or other reference methods.

Spectra are preprocessed, explored, and modeled with chemometric algorithms. We evaluate model behavior using calibration, cross-checking, and independent sample sets, then interpret influential spectral regions in relation to API, excipient, moisture, or solid-state features.

You receive a clear technical report covering spectral results, model performance, limitations, sample handling recommendations, and next-step guidance for broader application, model update, or integration with development workflows.
NIR spectra often contain broad, overlapping bands from C-H, O-H, N-H, and combination vibrations. BOC Sciences addresses this challenge through careful preprocessing, variable selection, matrix-aware calibration design, and orthogonal confirmation. When molecular assignments are uncertain, we incorporate NMR testing or targeted chromatographic results to distinguish chemical change from physical scatter effects.
Water can dominate NIR response and mask more subtle API or excipient signals. We design humidity-controlled experiments, collect spectra across relevant hydration states, and connect spectral changes with stability studies to help clients understand whether observed variation reflects reversible moisture uptake, chemical degradation, or processing-related structural change.
Powders and granules can show strong spectral differences caused by particle size, packing density, surface roughness, or agglomeration. We combine replicate sampling, rotation strategies, scatter correction, and particle size distribution testing so chemometric models remain focused on meaningful chemical or formulation attributes rather than uncontrolled physical artifacts.
Low API levels, chemically similar excipients, and non-uniform microenvironments can make NIR prediction difficult. We overcome these limitations through design-of-experiment sample sets, matrix balancing, expanded reference testing, spectral region selection, and model challenge samples that reveal where prediction is reliable and where another analytical approach should be paired with NIR.
Work with BOC Sciences to build NIR methods that are scientifically grounded, statistically defensible, and connected to real development needs. From API identity to moisture mapping and blend uniformity, we turn spectral complexity into practical insight.
Our NIR strategies are built for APIs, excipients, intermediates, and dosage-form matrices rather than generic material screening. We connect spectra with API analysis and formulation knowledge so results answer real development questions.
NIR response can be shaped by crystallinity, hydrate form, amorphous content, and particle morphology. Our team integrates polymorph screening, solid form screening and selection, and thermal analysis where needed.
We do not rely on spectra alone when reference data are essential. Our workflows can integrate impurity trends, moisture results, physical testing, and impurity profiling to ensure NIR models remain chemically meaningful.
Clients receive spectral libraries, model summaries, preprocessing parameters, performance statistics, sample handling instructions, and practical recommendations. For broader development programs, we align NIR outputs with analytical development and quality control needs.
Client Needs: A European formulation group needed rapid moisture assessment for a hygroscopic amorphous API blended with lactose and microcrystalline cellulose. Karl Fischer data were available, but destructive testing consumed limited development material and did not capture spatial heterogeneity.
Challenges: Water bands dominated the spectra, while particle packing and humidity exposure created inconsistent scattering. The client needed a model that could distinguish true water uptake from changes caused by sampling depth or powder compaction.
Solution: BOC Sciences designed humidity-conditioned calibration sets across six moisture levels and collected triplicate diffuse-reflectance spectra with controlled cup packing. We applied SNV, second-derivative preprocessing, and PLS regression, then compared predictions with Karl Fischer reference values. Outlier diagnostics identified two over-compressed samples, and the final model was challenged with independent lots and a 48-hour humidity cycling experiment.
Outcome: The client obtained a non-destructive moisture mapping workflow that reduced sample consumption, flagged handling-sensitive lots, and supported more informed drying and storage decisions during formulation development.
Client Needs: A U.S. drug development team required an NIR approach to evaluate low-dose API distribution in a ternary powder blend before tablet compression. Their existing grab-sample assay missed segregation events near blender discharge.
Challenges: The API was present at less than 2% w/w and had spectral features overlapping with a polymeric binder. Blend density, sampling location, and particle size distribution all influenced the NIR response.
Solution: We prepared a design-of-experiment blend matrix spanning API level, binder ratio, and particle size. Static and rotating-cup spectra were collected at 12 sampling points per blend, then modeled using interval PLS and PCA residual monitoring. Orthogonal HPLC assay data anchored the calibration, while simulated discharge samples tested the model's ability to detect segregation at practical decision points.
Outcome: The resulting model identified blend convergence earlier than the client's original endpoint strategy and revealed discharge-associated segregation patterns that guided revised mixing and sampling conditions.
Client Needs: A biotech partner developing an inhalation candidate needed a rapid method to distinguish two crystalline forms of a micronized steroid-like API after jet milling and storage under controlled humidity.
Challenges: The target polymorphs showed subtle NIR differences, and milling changed particle size enough to create strong scatter effects. The client needed to know whether spectral drift indicated form conversion or only physical change.
Solution: BOC Sciences paired NIR spectra with PXRD and DSC reference characterization across unmilled, micronized, and humidity-stressed samples. Multiplicative scatter correction and selected wavelength windows minimized particle-size interference. We built a SIMCA classification model, tested 36 blinded samples, and reviewed misclassification risk using score-distance plots, residual spectra, and replicate measurements from different vial orientations.
Outcome: The final workflow separated polymorphic change from milling-induced scatter, helping the client prioritize storage conditions and identify when additional solid-state analysis was needed.
Near-infrared spectroscopy analysis is suitable for a wide range of pharmaceutical R&D and process-related samples, including APIs, excipients, powder blends, granules, tablets, lyophilized materials, liquid formulation intermediates, and water-containing systems. Its advantages include minimal sample preparation, rapid data acquisition, and low sample destructiveness, making it especially useful for raw material identification, batch-to-batch comparison, component screening, moisture trend monitoring, and process evaluation. For samples with complex matrices or overlapping spectral features, BOC Sciences can integrate chemometric methods to support classification or quantitative modeling and improve the interpretability of analytical results.
In drug development, teams often face challenges such as high sample consumption, long analytical cycles, limited repeat testing for moisture-sensitive or heat-sensitive materials, difficulty determining powder blending endpoints, and slow identification of batch differences. Near-infrared spectroscopy analysis enables rapid spectral acquisition to assess sample identity, moisture variation, blend uniformity, API concentration trends, and physical-state differences. Compared with single-point destructive testing, near-infrared spectroscopy analysis is particularly valuable for multi-batch, multi-time-point, and process-oriented studies. BOC Sciences can design tailored spectral acquisition strategies, model development plans, and data interpretation frameworks to help clients obtain actionable insights for formulation optimization, process understanding, and quality consistency evaluation.
Yes. Moisture evaluation is one of the most common pharmaceutical applications of near-infrared spectroscopy analysis. Near-infrared spectra are sensitive to vibrational absorptions associated with O-H, N-H, and C-H bonds, making the technique useful for observing moisture changes, drying trends, lyophilized sample status, and water-related differences in powders or granules. For moisture-focused projects, BOC Sciences typically combines representative sample sets, spectral preprocessing, and multivariate modeling to build data models that reflect moisture trends or sample-state variation. This approach is especially useful when clients need to rapidly compare samples produced from different batches, drying conditions, or storage environments.
Near-infrared spectroscopy analysis can assess blend uniformity by collecting spectral information from powder blends, granules, or intermediates at different locations and time points, helping evaluate the distribution consistency of APIs, excipients, or other key components. For blend uniformity projects, BOC Sciences designs sampling strategies according to sample characteristics and applies chemometric tools such as principal component analysis and partial least squares modeling to identify spectral differences, monitor blending trends, and support process endpoint determination. Compared with relying only on limited sampling tests, near-infrared spectroscopy analysis provides richer process information and helps clients understand blending behavior, optimize mixing time, and reduce batch variability.
A near-infrared spectroscopy analysis report typically includes sample information, testing conditions, spectral acquisition mode, raw and preprocessed spectra, interpretation of key absorption regions, similarity or difference analysis among samples, chemometric modeling results, qualitative classification conclusions, quantitative prediction results, or process trend evaluation. For drug development projects, these results can help clients assess raw material and excipient consistency, formulation batch differences, drying or blending process changes, and whether complementary analytical techniques may be needed for further confirmation. BOC Sciences can also provide customized data interpretation based on project objectives, such as comparing different formulations, process parameters, or storage conditions to support formulation optimization and process development.
BOC Sciences did more than generate spectra. Their team explained which regions were chemically meaningful, where scattering affected our powders, and how the model should be used in daily development decisions.
— Dr. Preston, Senior Analytical Scientist
We needed a partner that understood both spectroscopy and formulation complexity. The chemometric model BOC Sciences delivered helped us detect blend variability that our routine sampling approach had missed.
— Ballard, Director of Formulation Development
Our hygroscopic API was difficult to handle, and destructive moisture tests were slowing us down. Their NIR workflow gave us a clearer view of water uptake across multiple lots and handling conditions.
— Dr. Cummings, Drug Product Development Lead
The BOC Sciences team built a method around our actual decision problem, not a generic instrument output. Their report was technically detailed, easy to discuss with project stakeholders, and immediately useful.
— Thornton, CMC Project Manager
If you have any questions or encounter issues on this page, please don't hesitate to reach out. Our support team is ready to assist you.